Whether you were there on Fri. Sept. 9th or wished you were – Come see the TrailBlazer event festivities Video!
Now online. Visit at: www.pm360TrailblazerAwards.com

Join us next year and we along with the industry will see you Here.

Panorama

Copay Coupons: Should They Stay or Should They Go?

Community Catalyst has laid out its case for why copay coupons should be illegal. Now pharma, doctors, pharmaceutical consulting groups, and others weigh in on whether these coupons really will lead to more harm than good. Read more.
Washington Wire

Overtime of a Salesman

When is a salesman not a salesman? That was the question facing the U.S. Supreme Court on April 16, as it heard oral arguments in Michael Shane Christopher, et al. v. SmithKline Beecham Corporation, d/b/a GlaxoSmithKline, considering whether pharmaceutical sales representatives are outside sales people, exempt from overtime payments required by the Fair Labor Standards Act of Decision. Read More.
Trends to Watch

Should Pharma be Interested in Pinterest?

Last month, Panorama asked for the industry’s take on Pinterest and its meteoric growth. The responses include Novo Nordisk’s plan for the interest-based social media site, the opinions of marketers on what kind of value the site can have for pharma, and, of course, the regulatory headaches to be aware of. Read More.

Click here for the full content from the current issue of Panorama

HOT TOPICS
FDA’S SCIENTISTS SAY POLITICAL INFLUENCE ‘TOO HIGH’
Scientists at the FDA feel that despite the agency’s attempts to improve scientific integrity, several areas are still lacking, according to a 33-question survey conducted by the Union of Concerned Scientists (UCS). A total of 997 FDA scientists responded to the survey, with 30% saying that they felt political interests had “a lot of weight in the FDA’s final decisions” and 55% believing that such influence was “too high.” Not all of the findings were negative, however,.…
The Scientists’ Take

In the same survey conducted by the Union of Concerned Scientists, respondents were also asked to make general comments as well as address specific areas. The scientists did not hold back. On Management and Scientific Development Concerns “There is a serious trend in some disciplines in CDER to overlook the complexity of science as it applies to drug development, to assume that we have complete knowledge of how the human body works and to latch onto simplistic theories and explanations to make safety problems go away.…

To Access ALL of PM360's Experts on Call Click Here!
FEATURES
PM360 COVER STORY: Patient Adherence: Initiating the Journey toward Collaboration
By Thomas Forissier
As healthcare payment systems increasingly emphasize outcomes, stakeholders—manufacturers, providers, pharmacies, and payers—will have to work together to understand the dynamics of patient adherence (and non-adherence) and address them creatively to engage the patient in successful treatment.
EXTENDED ONLINE ARTICLE: Marrying Patients to Adherence Begins with Engagement
By Jay H. Bolling
Here is a distillation of the learning, approaches and techniques that have significantly increased patient adherence rates over the past 20 years. The greatest success in promoting adherence is realized through applying some core principles of behavioral psychology.
THE EXTENDED BRAND—a Recipe for Success in a Customer-Centric World
By Jim McDonough
Going beyond the pill to offer value-added services is helping companies from Incyte to Pfizer build brands that patients embrace as caring and trusted partners.
PM360 THINK TANK: The Challenges of Managing Global Brands
With Christian Bauman, Nick Colucci, Joe Daley, David Davidovic, Kurt Kessler, Mark Klapper, Richard T. Minoff, Emma Sergeant, David Paragamian
We ask industry experts how global brand management is changing and what it takes to manage a global brand.
Automating Business Analytics to Boost Marketing, Sales, and ROI
By Dharmendra Sahay and Maria Kliatchko
Recent improvements in technology and analytics will help pharmaceutical companies respond to market demand faster than ever before.
IN THIS ISSUE
Publisher's Letter Positive Outcomes
Guest Commentary Changing the Game…Mike Marett
Industry Briefs
Washington Wire On Healthcare Reform Douglas McCormick
DTC 360 Go Gray Wisely… Richard Meyer
Common Sense Establish Yourself as a Product Management Authority Bud Bilanich
Healthcare HighlightsFDA Scientists Slam Political Influence, FDA Update, and more
E-Source Choosing the Right Technology for Your Content Can Save You Money Ron Scalici
Life Style Immune systems need challenges, dumb use of QR codes, and more
Market Watch Overactive Bladder Market: Managing the Future Melissa Leonhauser
PR360 Keeping it Tweet and Simple Gil Bashe
Physician POV Earn a Black Belt in Adherence Stephen R. Feldman, MD, PhD
Calendar The quick reference for upcoming industry events
Cutting Edge Gadgets and gear for today's on-the-go professional
Movers & Shakers Career changes in the industry
PhotoFinish Lake Louise, Banff National Park, Alberta


Site ©2008-2012 AMS Group LLC.